Voyageur Pharmaceuticals (CVE:VM) Shares Up 24.2% – Should You Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 24.2% on Thursday . The company traded as high as C$0.21 and last traded at C$0.21. 280,394 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 537,707 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 21.2 %

The stock has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a fifty day moving average of C$0.10 and a two-hundred day moving average of C$0.07.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.